Onegevity Health Announces Strategic Licensing Agreement with Kirin and Mitsui to Bring Health Intelligence Metagenome+TM into Japanese Market

April 16, 2019 Off By BusinessWire

NEW YORK–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/guthealth?src=hash" target="_blank"gt;#guthealthlt;/agt;–Kirin Holdings Company, Limited, Mitsui & Co., Ltd., and Onegevity
Health
, a market leader in advanced Artificial Intelligence
(AI)-enabled insight solutions for prevention and wellness, today
announced a strategic collaboration to launch Onegevity Health’s testing
system in Japan, as well as to develop unique nutritional products,
leveraging the insights provided by Onegevity’s AI-based platform.

“We empower individuals to combine the best emerging research in the
fields of microbiome and artificial intelligence to better manage
chronic health issues,” said Onegevity Health CEO Paul Jacobson. “We
create tools that keep individuals at the center of healthcare, with
direct access to convenient, at-home testing and high-powered health
intelligence to develop actionable, personalized plans for the their
health goals.”

Earlier this year, Onegevity Health launched its first commercial
product, GutbioTM, to bring AI-based personalized insights
and recommendations to help individuals manage and improve gut health.
Onegevity will expand services later this year to include whole-genome
sequencing, blood testing, and data-driven nutritional product
development. Mitsui and Kirin’s unique experience in developing
international markets and innovative products, respectively, will
accelerate Onegevity’s efforts to scale health intelligence in consumer
markets.

“We are pleased to announce this strategic partnership with Onegevity to
bring personalized health and wellness solutions that will strengthen
the initiatives begun last year when Mitsui and Kirin made a joint
strategic investment in our partner company Thorne,” said Masami
Yokoyama, General Manager, NutriScience Division, Mitsui. “We will start
our collaboration by launching GutbioTM to accelerate our
efforts in this space.”

“I believe Onegevity Health’s AI platform, which integrates multiple
health-related data sources and generates insights from machine
learning, provides us with crucial knowledge to develop new nutritional
products, particularly in the pre- and pro-biotic spaces,” said Shinro
Fujita, General Manager of Corporate Strategy, Kirin Holdings. “This
strategic partnership reinforces our commitment to pursue data science
to accelerate health insights, advance novel research concepts, and
achieve precision in treatment, with the goal of improving customer
outcomes.”

About Onegevity Health

Based in New York, Onegevity Health delivers science-based,
consumer-friendly recommendations for customized nutrition,
clinically-studied supplements and pre- and pro-biotics to improve
health outcomes. Onegevity provides a comprehensive molecular portrait
and customized recommendations for an individual’s health based on
integrated analysis of longitudinal blood, genetics, and microbiome
profiles. Onegevity leverages partner company Thorne’s network of 35,000
physicians to offer convenient testing and powerful analytical tools to
improve preventative care and lower healthcare costs for their patients.

About Kirin

Kirin is a global, multi-industry food and beverages company
headquartered in Tokyo. Kirin manufactures and sells alcohol and
non-alcohol beverages globally through its underlying companies such as
Kirin Brewery (Japan), Kirin Beverage (Japan), Lion (Australia), and
Myanmar Brewery (Myanmar), as well as engages in pharmaceutical and
bio-chemical businesses through Kyowa Kirin and Kyowa Hakko Bio. Under
the long-term management vision “Kirin Group Vision 2027”, Kirin aims to
become a global leader in CSV, creating value in domains ranging from
food and beverages to pharmaceuticals. For more information, visit https://www.kirinholdings.co.jp/english/.

About Mitsui

Mitsui is one of the most diversified and comprehensive trading,
investment and service enterprises in the world, with 139 offices in 66
countries as of Apr, 2019. Utilizing its global operating locations,
network and information resources, Mitsui is multilaterally pursuing
business that ranges from product sales, worldwide logistics and
financing, through to the development of major international
infrastructure and other projects in the following fields: Iron & Steel
Products, Mineral & Metal Resources, Infrastructure Projects, Mobility,
Chemicals, Energy, Food, Food & Retail Management, Healthcare & Service,
IT & Communication Business, Corporate Development Business. Mitsui is
actively taking on challenges for global business innovation around the
world. For more information, visit http://www.mitsui.com.

Contacts

Brad Hennig
[email protected]
(415)
307-7856